Reduction of lymphopenia by cladribine tablets under retreatment guidelines: A long-term follow-up analysis of patients in the ORACLE-MS study

Category Primary study
ConferenceMultiple Sclerosis
Year 2016
This article has no abstract
Epistemonikos ID: 17df71aca1fb05fba23531d217c3be99010cd570
First added on: Apr 29, 2026